Literature DB >> 3545531

Regulation of large coronary arteries.

M A Young, S F Vatner.   

Abstract

The majority of studies on the control of coronary artery vasoactivity have examined changes in coronary blood flow and coronary vascular resistance, indices that primarily reflect regulation of small arterioles and precapillary vessels. With the emergence of coronary artery vasospasm as a significant cause of angina pectoris, myocardial infarction, and sudden death, the control of large coronary artery caliber has assumed more significance. It is clear that resistance coronary vessels and large coronary arteries differ in response to both pharmacologic and physiologic stimuli. Vasodilation of large coronary arteries may occur by direct action of agents on the arterial smooth muscle or by the indirect action of receptor occupation, changes in blood flow, or liberation of endothelial factors. These indirect factors appear to contribute also to responses to agents that constrict coronary smooth muscle directly or through the autonomic nervous system. Furthermore, the mechanisms responsible for control of large coronary vessels in the normal circulation are likely to be profoundly different from those in the presence of diseased vessels. For example, several factors associated with coronary artery disease--elevated plasma cholesterol levels, endothelial disruption, atherosclerosis, vascular stenosis, and aggregated platelets--all have important actions on the control of large coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545531     DOI: 10.1161/01.res.59.6.579

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Biaxial vasoactivity of porcine coronary artery.

Authors:  Yunlong Huo; Yana Cheng; Xuefeng Zhao; Xiao Lu; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Elimination of variable vasomotor tone in studies with repeated quantitative coronary angiography.

Authors:  S Jost; W Rafflenbeul; G H Reil; H J Trappe; D Gulba; H Hecker; U Gerhardt; I Knop
Journal:  Int J Card Imaging       Date:  1990

Review 3.  Mechanisms causing myocardial ischaemia.

Authors:  C W Buffington
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

4.  Muscarinic cholinergic receptors in the human right coronary artery: a receptor binding and autoradiographic study.

Authors:  F Amenta; M De Michele; P Strocchi; F Ferrante; P Gallo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

5.  Ca2+-desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary artery.

Authors:  Robert L Wardle; Min Gu; Yukisato Ishida; Richard J Paul
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

6.  Noradrenergic hyperinnervation may inhibit necrosis of coronary arterial smooth muscle cells in stroke-prone spontaneously hypertensive rats.

Authors:  M Kondo; T Fujiwara; T Miyazaki; M Terade; R Tabei
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

7.  Geometry of the conduit coronary artery in diastole is determined by the volume of the left and right ventricles.

Authors:  M Gerová; E Barta; M Stolárik; J Gero
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

8.  Reflex epicardial coronary vasoconstriction elicited by nicotine in anaesthetized dogs.

Authors:  C G Sobey; G J Dusting; O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

9.  Two-layer model of coronary artery vasoactivity.

Authors:  Yunlong Huo; Xuefeng Zhao; Yana Cheng; Xiao Lu; Ghassan S Kassab
Journal:  J Appl Physiol (1985)       Date:  2013-03-07

10.  Mechanisms of ergonovine-induced hyperconstriction of coronary artery after x-ray irradiation in pigs.

Authors:  S Egashira; W Mitsuoka; H Tagawa; T Kuga; H Tomoike; M Nakamura; A Takeshita
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.